Mr. Kaufman’s practice focuses on mergers and acquisitions, corporate finance and corporate governance. His practice emphasis is on high technology clients including semiconductor, software and biotechnology companies, privately held start-up companies and major investment banks. Mr. Kaufman has represented a wide variety of clients in: Mergers and acquisitions, Hostile takeovers representing both targets and unsolicited acquirers, Successful proxy contest engagements, Problems of capital formation for start-up entities Public financing, Public offerings by foreign companies in the United States Both public and private securities offerings representing issuers, underwriters and venture capital entities

Mr. Kaufman served as Chairman of the Board of Directors of the PRO Corporation and Rexall Corporation and on the Boards of Directors of:Qantel Corporation, Applied ImmunoSciences, Inc., FP International, Inc.

He has been a member of the American Bar Association Committee on Negotiated Acquisitions and Committee on Federal Regulation of Securities and was a member of the American Bar Association Committee on Corporate Laws, which rewrites the Model Business Corporation Act. Mr. Kaufman participated in the task force that drafted the American Bar Association Committee on Federal Regulation of Securities comments on Forms S-1, S-2, and S-3 under the 1933 Act.